SCHEMBL7590680

SCHEMBL7590680

CC1C(NC(=O)c2ccc(-c3cccc(F)c3)[nH]2)C2CCN1CC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 4/20 0.40
CHRNA4 P43681 4/20 0.40
DYRK1A Q13627 1/20 0.37
PTPN1 P18031 1/20 0.36
PTPN11 Q06124 1/20 0.36
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
CYP2C19 P33261 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CHRNA7 P36544 3/20 0.34
DRD2 P14416 1/20 0.34
DRD4 P21917 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7121913 1.00 CHRNB2 (0.40) CHRNB2CHRNA4DYRK1APTPN1PTPN11
SCHEMBL7225519 0.91 PTPN1 (0.38) CHRNB2CHRNA4DYRK1APTPN1PTPN11
SCHEMBL7181005 0.89 MLLT1 (0.40) CHRNB2CHRNA4PTPN1ALDH1A1CHRNA7
SCHEMBL7129660 0.89 CHRNA7 (0.38) CHRNB2CHRNA4PTPN1KMT2AMEN1
SCHEMBL7132559 0.89 MLLT1 (0.40) CHRNB2CHRNA4PTPN1ALDH1A1CHRNA7
SCHEMBL7117473 0.88 FLT3 (0.37) CHRNB2CHRNA4PTPN1ALDH1A1HPGD
SCHEMBL7597918 0.88 L3MBTL3 (0.37) CHRNB2CHRNA4PTPN1KMT2AMEN1
SCHEMBL7225384 0.88 CHRNB2 (0.40) CHRNB2CHRNA4KMT2AALDH1A1HPGD
SCHEMBL7124994 0.88 PTPN1 (0.35) CHRNB2CHRNA4PTPN1KMT2AMEN1
SCHEMBL7123200 0.88 L3MBTL3 (0.37) CHRNB2CHRNA4PTPN1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002015662-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO claimed